Testing a new method to improve prostate biopsy decisions
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing a new test (PROSTia) to see if it can help doctors decide when a prostate biopsy is needed for men with signs of possible prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being considered for a prostate biopsy because of high PSA, high PSA density, or a suspicious MRI finding.
- You have been told about the study and agree to join.
- You are a man aged 18 or older.
- You have health insurance and understand French.
- You can fill out a questionnaire, with help if needed.
- You have not had a prostate biopsy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
This study is checking how well a blood test (liquid biopsy) can find prostate cancer and compare it to a special PET scan (PSMA-PET). If you qualify, you might help improve how we track prostate cancer without needing more invasive biopsies.
This trial is testing a more personalized way to perform prostate biopsies. It's for men who have a suspicious finding on exam or imaging, or a higher PSA level, and who have had a special MRI that suggests cancer. The goal is to improve accuracy and reduce unnecessary biopsies.
This trial enrolls adults who are being evaluated or treated for possible or confirmed prostate cancer and allows researchers to collect prostate tissue. It may help improve understanding of prostate cancer over the course of diagnosis and standard care.
This trial is testing whether taking extra biopsy samples from specific areas seen on an MRI can better detect prostate cancer compared to the standard method of taking samples from all over the prostate. It may help men who have a suspicious MRI finding and a higher PSA level.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.